{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:52:45Z","timestamp":1789912365824,"version":"4.0.1"},"reference-count":99,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"DOI":"10.1093\/hmg\/ddr500","type":"journal-article","created":{"date-parts":[[2011,11,4]],"date-time":"2011-11-04T02:24:56Z","timestamp":1320373496000},"page":"664-680","source":"Crossref","is-referenced-by-count":28,"title":["An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors"],"prefix":"10.1093","volume":"21","author":[{"given":"Rodrigo A.","family":"Fuentealba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Marasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc I.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Piwnica-Worms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad C.","family":"Weihl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,11,3]]},"reference":[{"key":"key\n\t\t\t\t20170522162138_DDR500C1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522162138_DDR500C2","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1093\/hmg\/ddm213","article-title":"Polyglutamine diseases: emerging concepts in pathogenesis and therapy","volume":"16","author":"Shao","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1176\/ajp.140.6.728","article-title":"Psychiatric syndromes in Huntington's disease","volume":"140","author":"Caine","year":"1983","journal-title":"Am. J. Psychiatry"},{"key":"key\n\t\t\t\t20170522162138_DDR500C4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522162138_DDR500C5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522162138_DDR500C6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/2.10.1547","article-title":"Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15","volume":"2","author":"Stine","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C7","first-page":"16","article-title":"Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats","volume":"59","author":"Rubinsztein","year":"1996","journal-title":"Am. J. Hum Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C8","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","article-title":"Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology","volume":"96","author":"Scherzinger","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jmg.36.10.739","article-title":"A molecular investigation of true dominance in Huntington's disease","volume":"36","author":"Narain","year":"1999","journal-title":"J. Med. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nbd.2005.08.007","article-title":"Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models","volume":"21","author":"Graham","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20170522162138_DDR500C11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nchembio792","article-title":"Stochastic kinetics of intracellular huntingtin aggregate formation","volume":"2","author":"Colby","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C12","doi-asserted-by":"crossref","first-page":"11884","DOI":"10.1073\/pnas.182276099","article-title":"Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nsmb1215","article-title":"A toxic monomeric conformer of the polyglutamine protein","volume":"14","author":"Nagai","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nsmb.1570","article-title":"Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism","volume":"16","author":"Thakur","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C15","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1021\/bi011772q","article-title":"Amyloid-like features of polyglutamine aggregates and their assembly kinetics","volume":"41","author":"Chen","year":"2002","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170522162138_DDR500C16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522162138_DDR500C17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.tins.2008.07.004","article-title":"Polyglutamine neurodegeneration: protein misfolding revisited","volume":"31","author":"Williams","year":"2008","journal-title":"Trends Neurosci."},{"key":"key\n\t\t\t\t20170522162138_DDR500C18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1083\/jcb.143.6.1457","article-title":"Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation","volume":"143","author":"Perez","year":"1998","journal-title":"J. Cell. Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C19","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells","volume":"96","author":"Kazantsev","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/jmbi.2001.4850","article-title":"Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity","volume":"311","author":"Chen","year":"2001","journal-title":"J. Mol. Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C21","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C22","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522162138_DDR500C23","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","article-title":"Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins","volume":"24","author":"Huang","year":"1998","journal-title":"Somat. Cell Mol. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C25","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddq087","article-title":"Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction","volume":"19","author":"Yamanaka","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C26","doi-asserted-by":"crossref","first-page":"12934","DOI":"10.1073\/pnas.0404968101","article-title":"Effects of Q\/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro","volume":"101","author":"Derkatch","year":"2004","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/pri.4.1.11074","article-title":"Interdependence of amyloid formation in yeast: implications for polyglutamine disorders and biological functions","volume":"4","author":"Urakov","year":"2010","journal-title":"Prion"},{"key":"key\n\t\t\t\t20170522162138_DDR500C28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0092-8674(00)81467-1","article-title":"A critical role for amino-terminal glutamine\/asparagine repeats in the formation and propagation of a yeast prion","volume":"93","author":"DePace","year":"1998","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522162138_DDR500C29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1083\/jcb.200112104","article-title":"Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1","volume":"157","author":"Meriin","year":"2002","journal-title":"J. Cell Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0092-8674(01)00440-8","article-title":"Multiple Gln\/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion","volume":"106","author":"Osherovich","year":"2001","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522162138_DDR500C31","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1523\/JNEUROSCI.0783-09.2009","article-title":"Cross-seeding fibrillation of Q\/N-rich proteins offers new pathomechanism of polyglutamine diseases","volume":"29","author":"Furukawa","year":"2009","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522162138_DDR500C32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neures.2009.10.004","article-title":"The RNA-binding protein FUS\/TLS is a common aggregate-interacting protein in polyglutamine diseases","volume":"66","author":"Doi","year":"2010","journal-title":"Neurosci. Res."},{"key":"key\n\t\t\t\t20170522162138_DDR500C33","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1074\/jbc.M705306200","article-title":"RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells","volume":"283","author":"Doi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162138_DDR500C34","doi-asserted-by":"crossref","first-page":"26304","DOI":"10.1074\/jbc.M110.125039","article-title":"Interaction with polyglutamine aggregates reveals a Q\/N-rich domain in TDP-43","volume":"285","author":"Fuentealba","year":"2010","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162138_DDR500C35","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","article-title":"Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease","volume":"67","author":"Schwab","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C36","doi-asserted-by":"crossref","first-page":"11910","DOI":"10.1073\/pnas.97.22.11910","article-title":"A census of glutamine\/asparagine-rich regions: implications for their conserved function and the prediction of novel prions","volume":"97","author":"Michelitsch","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jmcb\/mjq005","article-title":"Polyglutamine diseases: Where does toxicity come from? What is toxicity? Where are we going?","volume":"2","author":"Takahashi","year":"2010","journal-title":"J. Mol. Cell Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng864","article-title":"A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila","volume":"30","author":"Kazantsev","year":"2002","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0896-6273(03)00697-4","article-title":"A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor","volume":"40","author":"Pollitt","year":"2003","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170522162138_DDR500C40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"issue":"Suppl. 4","key":"key\n\t\t\t\t20170522162138_DDR500C41","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1073\/pnas.182426599","article-title":"Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay","volume":"99","author":"Heiser","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-6-1","article-title":"Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation","volume":"6","author":"Wang","year":"2005","journal-title":"BMC Neurosci."},{"key":"key\n\t\t\t\t20170522162138_DDR500C43","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington's disease","volume":"16","author":"Aiken","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20170522162138_DDR500C44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1087057107299428","article-title":"Discovery of a novel small-molecule targeting selective clearance of mutant huntingtin fragments","volume":"12","author":"Coufal","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"key\n\t\t\t\t20170522162138_DDR500C45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/hmg\/ddh045","article-title":"A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor","volume":"13","author":"Piccioni","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1096\/fj.04-2578fje","article-title":"Altered proteasome structure, function, and oxidation in aged muscle","volume":"19","author":"Ferrington","year":"2005","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20170522162138_DDR500C47","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.0408936102","article-title":"A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C48","doi-asserted-by":"crossref","first-page":"e7275","DOI":"10.1371\/journal.pone.0007275","article-title":"RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation","volume":"4","author":"Doumanis","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170522162138_DDR500C49","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1534\/genetics.109.112516","article-title":"A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila","volume":"184","author":"Zhang","year":"2010","journal-title":"Genetics"},{"key":"key\n\t\t\t\t20170522162138_DDR500C50","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/hmg\/ddl135","article-title":"Biologically active molecules that reduce polyglutamine aggregation and toxicity","volume":"15","author":"Desai","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t20170522162138_DDR500C52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nchembio806","article-title":"A clinical drug library screen identifies astemizole as an antimalarial agent","volume":"2","author":"Chong","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522162138_DDR500C54","doi-asserted-by":"crossref","first-page":"10216","DOI":"10.1073\/pnas.90.21.10216","article-title":"Control of folding and membrane translocation by binding of the chaperone DnaJ to nascent polypeptides","volume":"90","author":"Hendrick","year":"1993","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C55","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1002\/j.1460-2075.1993.tb06097.x","article-title":"DnaK, DnaJ and GrpE form a cellular chaperone machinery capable of repairing heat-induced protein damage","volume":"12","author":"Schroder","year":"1993","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170522162138_DDR500C56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nsb0294-95","article-title":"A conserved loop in the ATPase domain of the DnaK chaperone is essential for stable binding of GrpE","volume":"1","author":"Buchberger","year":"1994","journal-title":"Nat. Struct. Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth779","article-title":"Real-time imaging of ligand-induced IKK activation in intact cells and in living mice","volume":"2","author":"Gross","year":"2005","journal-title":"Nat. Methods"},{"key":"key\n\t\t\t\t20170522162138_DDR500C58","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1074\/jbc.M609972200","article-title":"Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162138_DDR500C59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"key":"key\n\t\t\t\t20170522162138_DDR500C60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2010.03.023","article-title":"Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish","volume":"39","author":"van Bebber","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20170522162138_DDR500C61","doi-asserted-by":"crossref","first-page":"15714","DOI":"10.1074\/jbc.M109.098806","article-title":"Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162138_DDR500C62","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.biocel.2004.02.003","article-title":"Microtubule disruption inhibits autophagosome-lysosome fusion: implications for studying the roles of aggresomes in polyglutamine diseases","volume":"36","author":"Webb","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3940(02)00162-3","article-title":"Expanded polyglutamine stretches form an \u2018aggresome","volume":"323","author":"Shimohata","year":"2002","journal-title":"Neurosci. Lett."},{"key":"key\n\t\t\t\t20170522162138_DDR500C64","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.200510065","article-title":"Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway","volume":"172","author":"Yamamoto","year":"2006","journal-title":"J. Cell Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C65","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1124\/dmd.31.10.1240","article-title":"In vitro metabolism studies on the isoxazole ring scission in the anti-inflammatory agent lefluonomide to its active alpha-cyanoenol metabolite A771726: mechanistic similarities with the cytochrome P450-catalyzed dehydration of aldoximes","volume":"31","author":"Kalgutkar","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20170522162138_DDR500C66","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/brain\/124.9.1791","article-title":"Suppression of experimental autoimmune neuritis by leflunomide","volume":"124","author":"Korn","year":"2001","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170522162138_DDR500C67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0404.2010.01444.x","article-title":"Pathophysiology of multiple sclerosis and the place of teriflunomide","volume":"124","author":"Gold","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"key\n\t\t\t\t20170522162138_DDR500C68","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1212\/01.wnl.0000203121.04509.31","article-title":"A phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses","volume":"66","author":"O'Connor","year":"2006","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170522162138_DDR500C69","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/bi952168g","article-title":"The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase","volume":"35","author":"Davis","year":"1996","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170522162138_DDR500C70","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0006-2952(95)00255-X","article-title":"Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide","volume":"50","author":"Greene","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0969-2126(00)00077-0","article-title":"Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents","volume":"8","author":"Liu","year":"2000","journal-title":"Structure"},{"key":"key\n\t\t\t\t20170522162138_DDR500C72","doi-asserted-by":"crossref","first-page":"22467","DOI":"10.1074\/jbc.270.38.22467","article-title":"Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound","volume":"270","author":"Williamson","year":"1995","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162138_DDR500C73","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(25)12093-4","article-title":"The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis","volume":"275","author":"Cherwinski","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20170522162138_DDR500C74","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1042\/bj3360299","article-title":"Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide","volume":"336","author":"Bruneau","year":"1998","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t20170522162138_DDR500C75","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/ar0000509","article-title":"Inhibitors of de novo nucleotide biosynthesis as drugs","volume":"35","author":"Christopherson","year":"2002","journal-title":"Acc. Chem. Res."},{"key":"key\n\t\t\t\t20170522162138_DDR500C76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-2797(99)00144-1","article-title":"Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid","volume":"124","author":"Knecht","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"key\n\t\t\t\t20170522162138_DDR500C77","doi-asserted-by":"crossref","first-page":"30289","DOI":"10.1074\/jbc.M805517200","article-title":"Impaired protein aggregate handling and clearance underlie the pathogenesis of p97\/VCP-associated disease","volume":"283","author":"Ju","year":"2008","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162138_DDR500C78","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1073\/pnas.0907339106","article-title":"Measuring prions by bioluminescence imaging","volume":"106","author":"Tamguney","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C79","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1073\/pnas.1019034108","article-title":"Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease","volume":"108","author":"Watts","year":"2011","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162138_DDR500C80","doi-asserted-by":"crossref","first-page":"27081","DOI":"10.1074\/jbc.M111.257378","article-title":"Characterization of oligomer formation of amyloid-{beta} peptide using a split-luciferase complementation assay","volume":"286","author":"Hashimoto","year":"2011","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162138_DDR500C81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-5-45","article-title":"Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden","volume":"5","author":"O'Leary","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"key\n\t\t\t\t20170522162138_DDR500C82","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162138_DDR500C83","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1750-3639.2010.00430.x","article-title":"Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity","volume":"21","author":"Medina","year":"2011","journal-title":"Brain Pathol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C84","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1021\/bi700411k","article-title":"Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization","volume":"46","author":"Necula","year":"2007","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170522162138_DDR500C85","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.febslet.2009.06.042","article-title":"Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models","volume":"583","author":"Yamashita","year":"2009","journal-title":"FEBS Lett."},{"key":"key\n\t\t\t\t20170522162138_DDR500C86","doi-asserted-by":"crossref","first-page":"12398","DOI":"10.1074\/jbc.270.21.12398","article-title":"Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide","volume":"270","author":"Xu","year":"1995","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162138_DDR500C87","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4049\/jimmunol.162.4.2095","article-title":"Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression","volume":"162","author":"Manna","year":"1999","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C88","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.taap.2006.08.001","article-title":"Leflunomide or A77 1726 protect from acetaminophen-induced cell injury through inhibition of JNK-mediated mitochondrial permeability transition in immortalized human hepatocytes","volume":"217","author":"Latchoumycandane","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C89","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hep.21475","article-title":"Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury","volume":"45","author":"Latchoumycandane","year":"2007","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170522162138_DDR500C90","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.4049\/jimmunol.179.10.6479","article-title":"Leflunomide inhibits PDK1\/Akt pathway and induces apoptosis of human mast cells","volume":"179","author":"Sawamukai","year":"2007","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C91","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddi443","article-title":"Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1\/2 protects against mutant huntingtin-associated toxicity","volume":"15","author":"Apostol","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C92","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/hmg\/ddm134","article-title":"Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase","volume":"16","author":"Scappini","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522162138_DDR500C93","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522162138_DDR500C94","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4161\/pri.3.2.8754","article-title":"The expanding realm of prion phenomena in neurodegenerative disease","volume":"3","author":"Frost","year":"2009","journal-title":"Prion"},{"key":"key\n\t\t\t\t20170522162138_DDR500C95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170522162138_DDR500C96","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1189\/jlb.0504308","article-title":"Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide\u2014mechanisms independent of pyrimidine depletion","volume":"76","author":"Korn","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C97","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00415-009-0075-3","article-title":"Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis","volume":"256","author":"Merrill","year":"2009","journal-title":"J. Neurol."},{"key":"key\n\t\t\t\t20170522162138_DDR500C98","first-page":"1313","article-title":"Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis","volume":"11","author":"Palmer","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"key\n\t\t\t\t20170522162138_DDR500C99","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1128\/MCB.00079-08","article-title":"Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation","volume":"28","author":"Shao","year":"2008","journal-title":"Mol. Cell. Biol."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/21\/3\/664\/17258423\/ddr500.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T19:43:09Z","timestamp":1741894989000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddr500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,3]]},"references-count":99,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,11,3]]},"published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddr500","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,3]]}}}